Tag: Novo Nordisk
Next-Gen Obesity Drug Disappoints: Novo Nordisk Shares Drop
Novo Nordisk, a pharmaceutical giant, recently experienced a setback that sent shockwaves through the industry. The company's highly anticipated next-generation obesity drug, CagriSema, failed...
Critics question transparency as U.K. trade group lifts Novo Nordisk suspension
A U.K. trade group is preparing to lift a two-year suspension of Novo Nordisk due to "serious breaches" in promoting an obesity drug. The...
BREAKING NEWS
Navigating the Latest Movement in the Corporate Ladder
Exciting Changes at Ribometrix: Katie Warner Promoted to Chief Scientific OfficerIn a recent development at Ribometrix, a biotech company known for its cutting-edge RNA...
